Bemcentinib and gilteritinib inhibit cell growth and impair the endo-lysosomal and autophagy systems in an AXL-independent manner.
| Type | Publication |
|---|---|
| Authors | Zdzalik-Bielecka D, Kozik K, Poswiata A, Jastrzebski K, Jakubik M, Miaczynska M. |
| Year | 2022 |
| Journal | Mol Cancer Res. |
| Volume | 20(3):446-455 |
| Pages | doi: 10.1158/1541-7786.MCR-21-0444 |
| Source | Full text / source → |